From Indian divine oil to form to complement form, men's problems have been bothering many people since ancient times, and most people are ashamed to talk about it. Behind the silence, however, lies alarming data: according to statistics, ED (erectile dysfunction) is one of the most prevalent diseases of the male reproductive system. In China, the prevalence of ED in men older than 40 years is about 40%. According to the data disclosed by the Male Branch of the Chinese Medical Association, the overall prevalence of ED in mainland men is 26.1%, and the age is mainly between 30 and 50 years old, and the incidence trend increases significantly with age. China's anti-ED drug market has exceeded 10 billion yuan.
In the past few years, due to the influence of foreign original drug patents, imported drugs have monopolized the pricing power, and the three major andrology drugs such as sildenafil, tadalafil, and dapoxetine hydrochloride are all more than 100 yuan, which is a big test for the economic tolerance of domestic ED (impotence) and PE (premature ejaculation) patients.
In recent years, with the support of policies for domestic high-quality generic drugs, it has brought great benefits and unlimited potential to the industry. In 2014, with the expiration of sildenafil patent protection, domestic pharmaceutical companies submitted generic drug application documents one after another, and began to rush to grab the 10 billion market.
In terms of the quality of generic drugs, the state has put forward the quality standard of "drug consistency evaluation", which is a drug quality requirement in the "Twelfth Five-Year Plan for National Drug Safety", that is, the state requires generic drugs to be consistent with the quality and efficacy of the original drugs. Specifically, it is required that the impurity spectrum is consistent, the stability is consistent, and the dissolution law in vitro and in vitro is consistent.
With the introduction of "drug consistency evaluation", the andrology generic drug market has ushered in unprecedented changes. This transformation presents an opportunity for companies with innovative strength and market insight to emerge. The andrology drug brand "Habitual Love" is one of the leaders, with the corporate philosophy of "good medicine, good price, good service, good brand", the corner overtaking broke through. Taking the brand ranking of impotence and premature ejaculation on the Tmall platform in the past 30 days as an example, the "habitual love" brand ranks ahead and becomes a leader in the industry.
Data source: Business Advisor Backend
We are committed to providing high quality-to-price drugs for male users
Incubated in 2021, the "Yiai" brand is deeply involved in the andrology drug market, with a series of brand drugs including tadalafil, dapoxetine hydrochloride, sildenafil, etc., with a sales volume of nearly 100 million tablets in 2023.
The "Xiai" brand has a strong supply chain advantage and R&D advantage, invests tens of millions of R&D expenses every year, and the drugs produced have passed the highest level of national "consistency evaluation". In addition, in accordance with the relevant international API development guidelines of ICH, the R&D team separated nearly 40 process impurities and potential impurities involved in production through technical means to ensure high-quality products. The parent company of the "Xiai" brand was awarded the "National High-tech Enterprise" by the state and the "Specialized, Specialized and New" certification in Beijing.
In addition, the "Yiai" brand carefully selects GMP manufacturers, and uses modern production equipment and rigorous operation procedures in the production process. The advanced quality management and strict testing system have been recognized by the World Health Organization, and the whole production process has been certified by the World Health Organization.
With the help of strong supply chain advantages and R&D capabilities, the "Yiai" brand has an irresistible price advantage, and tadalafil at 5 yuan/tablet is only one-tenth of the price of imported Viagra, which greatly reduces the pressure on patients to purchase drugs.
At the same time, with the help of Dekai Pharmaceutical's strong chronic disease management capabilities, supported by big data construction, and centered on professional pharmacist services, the "Yiai" brand provides consumers with an omni-channel, full-scenario, and full-life cycle health management service experience. Provide one-to-one companion pharmaceutical services, and follow up and guide patients throughout the process. In the process of medication, patients have any questions, there are professional pharmacists or physicians to answer them. If there is a need for offline treatment, it also provides patients with a green channel for famous doctors and hospitals, and provides exclusive solutions anytime and anywhere.
We will continue to promote the development of the industry and the equal use of drugs by consumers
The domestic market for ED treatment drugs is gradually rising, and more and more men can look at andrology scientifically. However, from the overall situation, the development of andrology drugs in China is still lagging behind compared with foreign countries.
However, with the advent of the e-commerce era, it provides a convenient channel for men who are ashamed to speak up. For ED patients, the Internet not only opens up cognitive channels, allows more information to be popularized more efficiently, but also allows formal and good drugs to be purchased in a more convenient, affordable and private way. The "Habitual Love" brand is solving the unspeakable hidden for more patients. Professor Li Yinhe once said, "Human sex and love are not vulgar characters and behaviors, not trivial matters, but noble and important." ”